Segment Trend Report sample for Vietnam – Thank you February 7th, 2024 Segment Trend Report sample report for Vietnam: Thank you Campaign Uncategorised
Vietnam’s IVD market – sample report February 7th, 2024 Vietnam’s IVD market is expected to increase by 2.5% in the next five years. But what’s the outlook for the diagnostics industry, and what trends are shaping market demand and future growth across vital IVD segments? Campaign In-vitro diagnosticsPoint-of-care testing (POCT)AsiaVietnam
Point-of-care testing for infectious diseases January 24th, 2024 In a recent Q&A interview with Clearstate’s global managing director, Ivy Teh, we talked about the future of point-of-care testing (POCT) and other opportunities in the global market for testing of other infectious diseases. Clearstate Insights In-vitro diagnosticsPoint-of-care testing (POCT)GlobalIVD GatewayPoint-of-care testing (POCT)
Are there concerns with the supply chain for point-of-care testing reagents and controls in some parts of the world? January 24th, 2024 In a recent Q&A interview, Clearstate’s global managing director, Ivy Teh, talks about the opportunities and challenges facing point-of-care testing, and some of the concerns around supply chain management. Clearstate Insights In-vitro diagnosticsPoint-of-care testing (POCT)GlobalPoint-of-care testing (POCT)
What technology will revolutionise the point-of-care testing market? January 22nd, 2024 In a recent Q&A interview, Clearstate’s global managing director, Ivy Teh, talks about the importance of new technologies in the adoption of point-of-care testing. Clearstate Insights In-vitro diagnosticsPoint-of-care testing (POCT)GlobalPoint-of-care testing (POCT)
Webinar: What’s next for China’s medical devices market? 中国医疗器械市场展望 December 20th, 2023 Join Clearstate in an insightful webinar as we explore China’s healthcare and medical device industry and unfold the main industry and commercial trends for the country in 2023-2024. Campaign Uncategorised
Brazil’s IVD market – sample report December 5th, 2023 Brazil has faced significant challenges during the coronavirus pandemic, with the high mortality ranked second only to the United States. The country’s healthcare system, which has long suffered from inadequate funding, has struggled to cope with the crisis, exacerbated by a weak government response. In response to the emergence of the more contagious Omicron variant, the government implemented travel bans and other restrictions in December 2021. Campaign In-vitro diagnosticsAmericas
Macro and micro trends shaping the future of medtech in Latam November 13th, 2023 Macro and micro trends shaping the future of Medtech in Latam and Canada Campaign Global
Essential insights into Vietnam’s in-vitro diagnostics market – Thank you November 3rd, 2023 Essential insights into Vietnam’s in-vitro diagnostics market – Thank you Campaign
Essential insights into Vietnam’s in-vitro diagnostics market November 3rd, 2023 Vietnam’s IVD market, estimated at US$419.2m, faced a significant decline in 2022 from the previous year’s market size. This is caused by a decrease in point-of-care (POC) and molecular diagnostics (MDx) segments and fewer rapid antigen tests as pandemic restrictions were lifted. Campaign Centralised Diagnostics (CEDx)In-vitro diagnosticsInfectious Diseases Testing MonitorPoint-of-care testing (POCT)AsiaVietnam
Healthcare outlook 2024 November 1st, 2023 A recovery in the global economy will cause a return to spending growth in the healthcare sector. However, it will remain vulnerable to headwinds, including limited resources, stricter regulations and continued strikes. Campaign Cardiovascular surgeryCentralised Diagnostics (CEDx)Covid-19 testingGeneral surgeryIn-vitro diagnosticsInfectious Diseases Testing MonitorNext Generation Sequencing (NGS)Surgical deviceGlobal